{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:51Z","timestamp":1782920691189,"version":"3.54.5"},"reference-count":91,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["16\/93\/01"],"award-info":[{"award-number":["16\/93\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Parts of this abstract have been reproduced with permission from Walsh TS, Parker RA, Aitken LM, McKenzie CA, Emerson L, Boyd J,\n et al<\/jats:italic>\n .; A2B Trial Investigators. Dexmedetomidine- or clonidine-based sedation compared with propofol in critically ill patients: the A2B randomized clinical trial.\n JAMA<\/jats:italic>\n 2025;\n 334<\/jats:bold>\n :32\u201345. https:\/\/doi.org\/10.1001\/jama.2025.7200. Copyright \u00a9 2025, American Medical Association. All rights reserved, including those for text and datamining, AI training, and similar technologies.\n <\/jats:p>\n \n Background<\/jats:title>\n Most mechanically ventilated intensive care unit patients require sedation and analgesia for comfort. Current usual care is propofol-based sedation plus an opioid analgesic. The alpha2 agonists dexmedetomidine and clonidine are potential alternative sedatives, but their clinical and cost-effectiveness are uncertain.<\/jats:p>\n <\/jats:sec>\n \n Objective(s)<\/jats:title>\n To evaluate the clinical and cost-effectiveness and safety of alpha2 agonists (dexmedetomidine and clonidine) compared with propofol for sedating adult intensive care unit patients.<\/jats:p>\n <\/jats:sec>\n \n Design and methods<\/jats:title>\n Pragmatic open-label three-arm trial. Embedded process and economic evaluation.<\/jats:p>\n <\/jats:sec>\n \n Setting and participants<\/jats:title>\n \n Forty-one intensive care units in the UK. Recruitment from December 2018 to October 2023. Participants were 1437 adults within 48 hours of starting mechanical ventilation expected to require \u2265\u200548 hours of mechanical ventilation [analysis population: propofol (\n N<\/jats:italic>\n \u2005=\u2005471), dexmedetomidine (\n N<\/jats:italic>\n \u2005=\u2005457), and clonidine-based (\n N<\/jats:italic>\n \u2005=\u2005476) sedation]. Median time from intubation to randomisation was 21.0 (first, third quartile: 13.2, 31.3) hours.\n <\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n In all groups, bedside algorithms targeted a Richmond Agitation Sedation Scale of \u22122 to +\u20051 unless clinicians requested deeper sedation. Intervention groups\u2019 algorithms supported alpha2-agonist up-titration and propofol down-titration followed by sedation primarily with allocated alpha2 agonist. Supplemental propofol was permitted if required.<\/jats:p>\n <\/jats:sec>\n \n Outcomes<\/jats:title>\n Primary outcome was time to successful extubation, analysed allowing for death as a competing risk. Secondary outcomes included mortality, sedation quality, rates of delirium and cardiovascular adverse events. Long-term outcomes included: experience of intensive care unit care; anxiety, depression and post-traumatic stress; cognitive function; health-related quality of life.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Mean (standard deviation) patient age was 59.2 (14.9) years; 901 (65%) male. The sub-distribution hazard ratio for time to successful extubation for dexmedetomidine versus propofol was 1.09 (95% confidence interval 0.96 to 1.25;\n p<\/jats:italic>\n \u2005=\u20050.20) and for clonidine versus propofol was 1.05 (0.95 to 1.17;\n p<\/jats:italic>\n \u2005=\u20050.34), with hazard ratio\u2005>\u20051 favouring alpha2 agonist. Median (95% confidence interval) hours from randomisation to successful extubation was: propofol 162 (136 to 170); dexmedetomidine 136 (117 to 150); and clonidine 146 (124 to 168). There was no effect interaction with age, sepsis status, median Sequential Organ Failure Assessment Score, or median Prediction of Delirium in intensive care unit patients' delirium risk score. Delirium rates were similar, but agitation occurred at higher rate than propofol with both alpha2 agonists [dexmedetomidine vs. propofol risk ratio (95% confidence intervals) 1.54 (1.21 to 1.97); clonidine vs. propofol 1.55 (1.22 to 1.97)]. Rates of severe bradycardia (rate <\u200550\/minute) were higher with both alpha2 agonists compared with propofol [dexmedetomidine vs. propofol rate ratio (95% confidence interval) 1.62 (1.36 to 1.93); clonidine vs. propofol 1.58 (1.33 to 1.88)]. Mortality was similar over 180 days follow-up [dexmedetomidine vs. propofol hazard ratio (95% confidence interval) 0.98 (0.77 to 1.24); clonidine vs. propofol 1.04 (0.82 to 1.31)]. Process evaluation indicated a range of contextual factors at intensive care unit and individual level that influenced intervention delivery, including: intensive care unit culture, prior clinician opinions\/beliefs, staffing pressures (exacerbated by the COVID-19 pandemic), clinician experience and concerns about alpha2-agonist side effects. There was no difference in cost-effectiveness between the groups.\n <\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n This was a pragmatic unblinded trial, with associated risk of performance and ascertainment bias.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n Future trials should explore the effectiveness of alpha2 agonists as sedatives in other populations, for example paediatric critical care and acute brain injury.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In mechanically ventilated critically ill patients, neither dexmedetomidine- nor clonidine-based sedation was superior for major clinical outcomes or more cost-effective compared with propofol-based sedation.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16\/93\/01.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/gjtw3820","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:24:13Z","timestamp":1755692653000},"page":"1-94","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-8540","authenticated-orcid":true,"given":"Timothy S","family":"Walsh","sequence":"first","affiliation":[{"name":"Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-5022","authenticated-orcid":true,"given":"Richard A","family":"Parker","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-9090","authenticated-orcid":true,"given":"Leanne M","family":"Aitken","sequence":"additional","affiliation":[{"name":"City St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4250-5758","authenticated-orcid":true,"given":"Lydia","family":"Emerson","sequence":"additional","affiliation":[{"name":"City St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-9711","authenticated-orcid":true,"given":"Cathrine A","family":"McKenzie","sequence":"additional","affiliation":[{"name":"National Institute of Health and Social Care Research (NIHR), Biomedical Research Centre (BRC), Southampton, Perioperative and Critical Care Theme, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-3893","authenticated-orcid":true,"given":"Julia","family":"Boyd","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5130-9582","authenticated-orcid":true,"given":"Alix","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-659X","authenticated-orcid":true,"given":"Gayle","family":"Beveridge","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3713-8269","authenticated-orcid":true,"given":"Annabel","family":"Giddings","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7575-8153","authenticated-orcid":true,"given":"David","family":"Hope","sequence":"additional","affiliation":[{"name":"Edinburgh Critical Care Research Group, NHS Lothian, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9352-4951","authenticated-orcid":true,"given":"S\u00eean","family":"Irvine","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-6794","authenticated-orcid":true,"given":"Sharon","family":"Tuck","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-2779","authenticated-orcid":true,"given":"Nazir I","family":"Lone","sequence":"additional","affiliation":[{"name":"Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-8230","authenticated-orcid":true,"given":"Kalliopi","family":"Kydonaki","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, National and Kapodistrian, University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-9252","authenticated-orcid":true,"given":"John","family":"Norrie","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-1232","authenticated-orcid":true,"given":"Benedict","family":"Creagh-Brown","sequence":"additional","affiliation":[{"name":"Royal Surrey County Hospital NHS Foundation Trust, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-1947","authenticated-orcid":true,"given":"Daniel F","family":"McAuley","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-0164","authenticated-orcid":true,"given":"Paul","family":"Dark","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, Division of Immunology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2763-4316","authenticated-orcid":true,"given":"Matt P","family":"Wise","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0419-547X","authenticated-orcid":true,"given":"Anthony C","family":"Gordon","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-7548","authenticated-orcid":true,"given":"Gavin D","family":"Perkins","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-0707","authenticated-orcid":true,"given":"Michael C","family":"Reade","sequence":"additional","affiliation":[{"name":"Medical School, University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4583-5381","authenticated-orcid":true,"given":"Bronagh","family":"Blackwood","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-9370","authenticated-orcid":true,"given":"Alasdair","family":"MacLullich","sequence":"additional","affiliation":[{"name":"Ageing and Health, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Glen","sequence":"additional","affiliation":[{"name":"Lay member, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-2533","authenticated-orcid":true,"given":"Valerie J","family":"Page","sequence":"additional","affiliation":[{"name":"Intensive Care, West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-3563","authenticated-orcid":true,"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[{"name":"Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6494-4903","authenticated-orcid":true,"given":"Christopher J","family":"Weir","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2026,6]]},"reference":[{"key":"key2026070120124200_ref1-bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20250","article-title":"Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review","volume":"20","author":"Cruickshank","year":"2016","journal-title":"Health Technol Assess"},{"key":"key2026070120124200_ref2-bib2","doi-asserted-by":"crossref","first-page":"h2538","DOI":"10.1136\/bmj.h2538","article-title":"Outcome of delirium in critically ill patients: systematic review and meta-analysis","volume":"350","author":"Salluh","year":"2015","journal-title":"BMJ"},{"key":"key2026070120124200_ref3-bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/CCM.0b013e31828a409c","article-title":"Surviving intensive care: a systematic review of healthcare resource use after hospital discharge*","volume":"41","author":"Lone","year":"2013","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref4-bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/rccm.201511-2234OC","article-title":"Five-year mortality and hospital costs associated with surviving intensive care","volume":"194","author":"Lone","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"key2026070120124200_ref5-bib5","author":"Dextor \u2013 Orion Corporation"},{"key":"key2026070120124200_ref6-bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13054-015-0787-y","article-title":"Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation","volume":"19","author":"Turunen","year":"2015","journal-title":"Crit Care"},{"key":"key2026070120124200_ref7-bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/CEOR.S242994","article-title":"Cost-minimization analysis of dexmedetomidine compared to other sedatives for short-term sedation during mechanical ventilation in the United States","volume":"12","author":"Aggarwal","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"key2026070120124200_ref8-bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","article-title":"Critical care and the global burden of critical illness in adults","volume":"376","author":"Adhikari","year":"2010","journal-title":"Lancet"},{"key":"key2026070120124200_ref9-bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref10-bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00134-016-4297-4","article-title":"Comfort and patient-centred care without excessive sedation: the eCASH concept","volume":"42","author":"Vincent","year":"2016","journal-title":"Intensive Care Med"},{"key":"key2026070120124200_ref11-bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMra1208705","article-title":"Sedation and delirium in intensive care","volume":"370","author":"Reade","year":"2014","journal-title":"N Engl J Med"},{"key":"key2026070120124200_ref12-bib12","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/cc8956","article-title":"A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety","volume":"14","author":"Jackson","year":"2010","journal-title":"Crit Care"},{"key":"key2026070120124200_ref13-bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201203-0522OC","article-title":"Early intensive care sedation predicts long-term mortality in ventilated critically ill patients","volume":"186","author":"Shehabi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"key2026070120124200_ref14-bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-015-0929-2","article-title":"Early deep sedation is associated with decreased in-hospital and two-year follow-up survival","volume":"19","author":"Balzer","year":"2015","journal-title":"Crit Care"},{"key":"key2026070120124200_ref15-bib15","article-title":"Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation","volume":"2014","author":"Burry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026070120124200_ref16-bib16","article-title":"Protocol-directed sedation versus non-protocol-directed sedation to reduce duration of mechanical ventilation in mechanically ventilated intensive care patients","volume":"1","author":"Aitken","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026070120124200_ref17-bib17","doi-asserted-by":"crossref","first-page":"e024549","DOI":"10.1136\/bmjopen-2018-024549","article-title":"Challenges and barriers to optimising sedation in intensive care: a qualitative study in eight Scottish intensive care units","volume":"9","author":"Kydonaki","year":"2019","journal-title":"BMJ Open"},{"key":"key2026070120124200_ref18-bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/thoraxjnl-2020-216098","article-title":"Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis","volume":"76","author":"Aitken","year":"2021","journal-title":"Thorax"},{"key":"key2026070120124200_ref19-bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/jocn.12058","article-title":"\u2018Targeting\u2019 sedation: the lived experience of the intensive care nurse","volume":"23","author":"Everingham","year":"2014","journal-title":"J Clin Nurs"},{"key":"key2026070120124200_ref20-bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(09)62072-9","article-title":"A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial","volume":"375","author":"Str\u00f8m","year":"2010","journal-title":"Lancet"},{"key":"key2026070120124200_ref21-bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1906759","article-title":"Nonsedation or light sedation in critically ill, mechanically ventilated patients","volume":"382","author":"Olsen","year":"2020","journal-title":"N Engl J Med"},{"key":"key2026070120124200_ref22-bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.genhosppsych.2016.08.005","article-title":"Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis","volume":"43","author":"Nikayin","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"key2026070120124200_ref23-bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/CCM.0000000000000882","article-title":"Posttraumatic stress disorder in critical illness survivors: a metaanalysis","volume":"43","author":"Parker","year":"2015","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref24-bib24","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/CCM.0000000000001811","article-title":"Depressive symptoms after critical illness: a systematic review and meta-analysis","volume":"44","author":"Rabiee","year":"2016","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref25-bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.aucc.2015.11.004","article-title":"What is the relationship between elements of ICU treatment and memories after discharge in adult ICU survivors?","volume":"29","author":"Aitken","year":"2016","journal-title":"Aust Crit Care"},{"key":"key2026070120124200_ref26-bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1365-2044.2005.04336.x","article-title":"Predictors of emotional outcomes of intensive care","volume":"60","author":"Rattray","year":"2005","journal-title":"Anaesthesia"},{"key":"key2026070120124200_ref27-bib27","first-page":"944","article-title":"Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review","volume":"79","author":"Wade","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"key2026070120124200_ref28-bib28","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref29-bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00134-022-06660-x","article-title":"Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline","volume":"48","author":"M\u00f8ller","year":"2022","journal-title":"Intensive Care Med"},{"key":"key2026070120124200_ref30-bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13054-017-1610-8","article-title":"Clonidine for sedation in the critically ill: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2017","journal-title":"Crit Care"},{"key":"key2026070120124200_ref31-bib31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/jama.2025.3169","article-title":"Inhaled sedation in acute respiratory distress syndrome: the SESAR randomized clinical trial","volume":"333","author":"Jabaudon","year":"2025","journal-title":"JAMA"},{"key":"key2026070120124200_ref32-bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ccc.2025.05.007","article-title":"Pharmacology of alpha-2 agonists applied to sedation, sleep, and analgesia","volume":"41","author":"McKenzie","year":"2025","journal-title":"Crit Care Clin"},{"key":"key2026070120124200_ref33-bib33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","article-title":"Long-term cognitive impairment after critical illness","volume":"369","author":"Pandharipande","year":"2013","journal-title":"N Engl J Med"},{"key":"key2026070120124200_ref34-bib34","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2165\/11635520-000000000-00000","article-title":"Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management","volume":"72","author":"Zaal","year":"2012","journal-title":"Drugs"},{"key":"key2026070120124200_ref35-bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.202010-3794OC","article-title":"Opioid use increases the risk of delirium in critically ill adults independently of pain","volume":"204","author":"Duprey","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"key2026070120124200_ref36-bib36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(16)30178-3","article-title":"Staff education, regular sedation and analgesia quality feedback, and a sedation monitoring technology for improving sedation and analgesia quality for critically ill, mechanically ventilated patients: a cluster randomised trial","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir Med"},{"key":"key2026070120124200_ref37-bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/CCM.0000000000001463","article-title":"Development of process control methodology for tracking the quality and safety of pain, agitation, and sedation management in critical care units","volume":"44","author":"Walsh","year":"2016","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref38-bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13054-016-1532-x","article-title":"National survey and point prevalence study of sedation practice in UK critical care","volume":"20","author":"Richards-Belle","year":"2016","journal-title":"Crit Care"},{"key":"key2026070120124200_ref39-bib39","article-title":"Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients","volume":"1","author":"Chen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026070120124200_ref40-bib40","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.2017.2088","article-title":"Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial","volume":"317","author":"Kawazoe","year":"2017","journal-title":"JAMA"},{"key":"key2026070120124200_ref41-bib41","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc8916","article-title":"Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial","volume":"14","author":"Pandharipande","year":"2010","journal-title":"Crit Care"},{"key":"key2026070120124200_ref42-bib42","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","article-title":"Early sedation with dexmedetomidine in critically ill patients","volume":"380","author":"Shehabi","year":"2019","journal-title":"N Engl J Med"},{"key":"key2026070120124200_ref43-bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00134-021-06356-8","article-title":"Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial","volume":"47","author":"Shehabi","year":"2021","journal-title":"Intensive Care Med"},{"key":"key2026070120124200_ref44-bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/rccm.202206-1208OC","article-title":"Dexmedetomidine and propofol sedation in critically ill patients and dose-associated 90-day mortality: a secondary cohort analysis of a randomized controlled trial (SPICE III)","volume":"207","author":"Shehabi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"key2026070120124200_ref45-bib45","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJMoa2024922","article-title":"Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis","volume":"384","author":"Hughes","year":"2021","journal-title":"N Engl J Med"},{"key":"key2026070120124200_ref46-bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-022-06712-2","article-title":"Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lewis","year":"2022","journal-title":"Intensive Care Med"},{"key":"key2026070120124200_ref47-bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bja.2022.06.020","article-title":"Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials","volume":"129","author":"Heybati","year":"2022","journal-title":"Br J Anaesth"},{"key":"key2026070120124200_ref48-bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/aas.14208","article-title":"Dexmedetomidine for the prevention of delirium in adults admitted to the intensive care unit or post-operative care unit: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis","volume":"67","author":"Maagaard","year":"2023","journal-title":"Acta Anaesthesiol Scand"},{"key":"key2026070120124200_ref49-bib49","doi-asserted-by":"crossref","first-page":"110157","DOI":"10.1016\/j.jclinane.2020.110157","article-title":"Effect of dexmedetomidine on delirium during sedation in adult patients in intensive care units: a systematic review and meta-analysis","volume":"69","author":"Wang","year":"2021","journal-title":"J Clin Anesth"},{"key":"key2026070120124200_ref50-bib50","doi-asserted-by":"crossref","first-page":"h1258","DOI":"10.1136\/bmj.h1258","article-title":"Process evaluation of complex interventions: Medical Research Council guidance","volume":"350","author":"Moore","year":"2015","journal-title":"BMJ"},{"key":"key2026070120124200_ref51-bib51","doi-asserted-by":"crossref","first-page":"a1655","DOI":"10.1136\/bmj.a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ"},{"key":"key2026070120124200_ref52-bib52","doi-asserted-by":"crossref","first-page":"e078645","DOI":"10.1136\/bmjopen-2023-078645","article-title":"Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK","volume":"13","author":"Walsh","year":"2023","journal-title":"BMJ Open"},{"key":"key2026070120124200_ref53-bib53","doi-asserted-by":"crossref","first-page":"e081637","DOI":"10.1136\/bmjopen-2023-081637","article-title":"Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B trial): protocol for a mixed-methods process evaluation of a randomised controlled trial","volume":"14","author":"Aitken","year":"2024","journal-title":"BMJ Open"},{"key":"key2026070120124200_ref54-bib54","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"key":"key2026070120124200_ref55-bib55","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"key2026070120124200_ref56-bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2648.2004.03066.x","article-title":"The intensive care experience: development of the ICE questionnaire","volume":"47","author":"Rattray","year":"2004","journal-title":"J Adv Nurs"},{"key":"key2026070120124200_ref57-bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/occmed\/kqu024","article-title":"The hospital anxiety and depression scale","volume":"64","author":"Stern","year":"2014","journal-title":"Occup Med (Lond)"},{"key":"key2026070120124200_ref58-bib58","volume-title":"The Impact of Event Scale \u2013 Revised","author":"Weiss","year":"1997"},{"key":"key2026070120124200_ref59-bib59","doi-asserted-by":"crossref","first-page":"e12144","DOI":"10.1002\/dad2.12144","article-title":"T-MoCA: a valid phone screen for cognitive impairment in diverse community samples","volume":"13","author":"Katz","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"key2026070120124200_ref60-bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jama.2025.7200","article-title":"Dexmedetomidine or clonidine-based sedation compared with propofol in critically ill patients: the A2B randomized clinical trial","volume":"334","author":"Walsh","year":"2025","journal-title":"JAMA"},{"key":"key2026070120124200_ref61-bib61","author":"Dexdor \u2013 direct healthcare professional communication (DHPC)","year":"2022"},{"key":"key2026070120124200_ref62-bib62","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/thoraxjnl-2017-210822","article-title":"Predicting risk of unplanned hospital readmission in survivors of critical illness: a population-level cohort study","volume":"74","author":"Lone","year":"2019","journal-title":"Thorax"},{"key":"key2026070120124200_ref63-bib63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"key2026070120124200_ref64-bib64","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1136\/bmj.e420","article-title":"Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study","volume":"344","author":"van den Boogaard","year":"2012","journal-title":"BMJ"},{"key":"key2026070120124200_ref65-bib65","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-019-2690-4","article-title":"The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies","volume":"23","author":"Flanders","year":"2019","journal-title":"Crit Care"},{"key":"key2026070120124200_ref66-bib66","doi-asserted-by":"crossref","DOI":"10.3310\/GJTW2718","article-title":"Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT","author":"Walsh","year":"2026","journal-title":"Health Technol Assess"},{"key":"key2026070120124200_ref67-bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.genhosppsych.2016.07.004","article-title":"Distribution-based estimates of minimal important difference for hospital anxiety and depression scale and impact of event scale-revised in survivors of acute respiratory failure","volume":"42","author":"Chan","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"key2026070120124200_ref68-bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/GJTW0620","article-title":"An exploration of the factors influencing successful implementation, delivery and outcomes in an intensive care sedation study: process evaluation of the A2B RCT","author":"Aitken","year":"2025","journal-title":"Health Technol Assess"},{"key":"key2026070120124200_ref69-bib69","first-page":"17511437251381951","article-title":"The experiences of bedside nurses delivering an intensive care sedation study: a process evaluation within the A2B trial","author":"Emerson","year":"2025","journal-title":"J Intensive Care Soc"},{"key":"key2026070120124200_ref70-bib70","doi-asserted-by":"crossref","first-page":"e25175","DOI":"10.1001\/jamanetworkopen.2025.17533","article-title":"Cost-effectiveness of \u03b12 agonists for intravenous sedation in patients with critical illness","volume":"8","author":"Morris","year":"2025","journal-title":"JAMA Netw Open"},{"key":"key2026070120124200_ref71-bib71","doi-asserted-by":"crossref","first-page":"n2061","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"key2026070120124200_ref72-bib72","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","article-title":"Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)","volume":"289","author":"Ely","year":"2003","journal-title":"JAMA"},{"key":"key2026070120124200_ref73-bib73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/cc5787","article-title":"Clinical review: agitation and delirium in the critically ill \u2013 significance and management","volume":"11","author":"Chevrolet","year":"2007","journal-title":"Crit Care"},{"key":"key2026070120124200_ref74-bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nicc.12643","article-title":"Critically ill patients\u2019 experience of agitation: a qualitative meta-synthesis","volume":"27","author":"Freeman","year":"2022","journal-title":"Nurs Crit Care"},{"key":"key2026070120124200_ref75-bib75","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.eclinm.2024.102569","article-title":"Effect of level of sedation on outcomes in critically ill adult patients: a systematic review of clinical trials with meta-analysis and trial sequential analysis","volume":"71","author":"Ceric","year":"2024","journal-title":"EClinicalMedicine"},{"key":"key2026070120124200_ref76-bib76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.201810-2050CP","article-title":"Reappraisal of ventilator-free days in critical care research","volume":"200","author":"Yehya","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key2026070120124200_ref77-bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13054-023-04562-y","article-title":"Sample size estimation in clinical trials using ventilator-free days as the primary outcome: a systematic review","volume":"27","author":"Renard Trich\u00e9","year":"2023","journal-title":"Crit Care"},{"key":"key2026070120124200_ref78-bib78","first-page":"e20240246en","article-title":"Alternative approaches to analyzing ventilator-free days, mortality and duration of ventilation in critical care research","volume":"36","author":"Serpa Neto","year":"2024","journal-title":"Crit Care Sci"},{"key":"key2026070120124200_ref79-bib79","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2016.2707","article-title":"Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial","volume":"315","author":"Reade","year":"2016","journal-title":"JAMA"},{"key":"key2026070120124200_ref80-bib80","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13054-023-04618-z","article-title":"Use of dexmedetomidine in critical-ill patients: is it time to look to the actual evidence?","volume":"27","author":"P\u00e9rez-Nieto","year":"2023","journal-title":"Crit Care"},{"key":"key2026070120124200_ref81-bib81","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1097\/CCM.0000000000006574","article-title":"A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"53","author":"Lewis","year":"2025","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref82-bib82","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/CCM.0000000000005049","article-title":"Design of clinical trials evaluating sedation in critically ill adults undergoing mechanical ventilation: recommendations from sedation consortium on endpoints and procedures for treatment, education, and research (SCEPTER) recommendation III","volume":"49","author":"Ward","year":"2021","journal-title":"Crit Care Med"},{"key":"key2026070120124200_ref83-bib83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bja.2024.06.007","article-title":"Effectiveness of dexmedetomidine on patient-centred outcomes in surgical patients: a systematic review and Bayesian meta-analysis","volume":"133","author":"Verret","year":"2024","journal-title":"Br J Anaesth"},{"key":"key2026070120124200_ref84-bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/anae.15947","article-title":"Dexmedetomidine for adult cardiac surgery: a systematic review, meta-analysis and trial sequential analysis","volume":"78","author":"Poon","year":"2023","journal-title":"Anaesthesia"},{"key":"key2026070120124200_ref85-bib85","volume-title":"Improving Inclusion of Under-served Groups in Clinical Research: Guidance from INCLUDE Project","author":"National Institute for Health and Care Research"},{"key":"key2026070120124200_ref86-bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1751143715609954","article-title":"Research priorities by professional background \u2013 a detailed analysis of the James Lind Alliance Priority Setting Partnership","volume":"17","author":"Arulkumaran","year":"2016","journal-title":"J Intensive Care Soc"},{"key":"key2026070120124200_ref87-bib87","author":"Critical Care Reviews (CCRs)","year":"2024"},{"key":"key2026070120124200_ref88-bib88","first-page":"13","article-title":"Dexmedetomidine: a novel sedative-analgesic agent","volume":"14","author":"Gertler","year":"2001","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"key2026070120124200_ref89-bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.anclin.2017.01.009","article-title":"Alpha-2 agonists","volume":"35","author":"Nguyen","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"key2026070120124200_ref90-bib90","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/03639045.2016.1232727","article-title":"Pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"42","author":"Li","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"key2026070120124200_ref91-bib91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0970-9185.74581","article-title":"Clonidine in adults as a sedative agent in the intensive care unit","volume":"26","author":"Jamadarkhana","year":"2010","journal-title":"J Anaesthesiol Clin Pharmacol"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2051392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/GJTW3820\/GJTW3820.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2051392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:52:55Z","timestamp":1782917575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/published-articles\/GJTW3820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":91,"alternative-id":["10.3310\/GJTW3820"],"URL":"https:\/\/doi.org\/10.3310\/gjtw3820","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"04-2018","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"02-2025","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"10-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}